The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID-19 variants.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.
How monoclonal antibodies lost the fight with new COVID variants wlrn.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wlrn.org Daily Mail and Mail on Sunday newspapers.